top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

McKesson to Acquire Precision Medicine Group in $2.25B Deal to Expand Clinical Services

11 minutes ago
1 min read

Irving, TX, August 25, 2026 (Reuters) -- McKesson has agreed to acquire Precision Medicine Group in a transaction valued at approximately $2.25 billion. Precision provides clinical research, laboratory testing, and commercialization services to pharmaceutical and biotechnology companies, complementing McKesson’s existing oncology and multispecialty operations. The acquisition is expected to strengthen McKesson’s clinical trial capabilities and broaden its higher-growth healthcare services portfolio.

Read full article here.

Recent Posts

InduPro Raises $77M Series B to Advance Precision Oncology Pipeline

Seattle and Cambridge, MA, August 12, 2026 (Yahoo Finance) -- InduPro has closed a $77 million Series B financing led by The Column Group to fund development of its cancer-focused therapeutic pipeli

Juvena Therapeutics Appoints Julie Anne Smith as Chief Executive Officer

RedWood City, CA, August 17, 2026 (Yahoo Finance) -- Juvena Therapeutics has appointed Julie Anne Smith as chief executive officer to lead the company’s next stage of growth. Smith brings extensive

Amylyx Pharmaceuticals Prices Upsized $500M Public Offering to Support Pipeline Growth

Cambridge, MA, August 19, 2026 (Business Wire) -- Amylyx Pharmaceuticals has priced an upsized public offering expected to generate approximately $500 million in gross proceeds. The company plans to

Comments

Life Science Headlines

InduPro Raises $77M Series B to Advance Precision Oncology Pipeline

Juvena Therapeutics Appoints Julie Anne Smith as Chief Executive Officer

Amylyx Pharmaceuticals Prices Upsized $500M Public Offering to Support Pipeline Growth

Longevica Therapeutics Names Ex-Genentech Executive Prasun Mishra as CEO to Advance Longevity Drug Development

McKesson to Acquire Precision Medicine Group in $2.25B Deal to Expand Clinical Services

Bridge Life Sciences Raises $110M to Advance Drug Development Pipeline

PacBio Names Mark Van Oene as President and Chief Executive Officer

Tarsus to Acquire Alkeus in Up to $800M Deal to Expand Ophthalmology Pipeline

Versa Vascular Appoints Bill Shields as CEO to Drive Next Phase of Growth

Jazz Pharmaceuticals to Acquire Actio Biosciences in Up to $1.32B Deal for Rare Epilepsy Treatment

bottom of page